- Hypertension

- Gastrointestinal: diarrhea, constipation, abdominal pain

- Nausea and vomiting

- Headache

- Fatigue

- Decreased weight

- Suppressed appetite

- Dysphonia

- Dysgeusia

- Rash

- Myalgia

- Cardiac dysfunction

- Arterial thromboembolic event

- Hepatotoxicity

- Renal failure or impairment

- Proteinuria

- Gastrointestinal perforation

- Fistula formation

- QT prolongation

- Reversible posterior leukoencephalopathy syndrome

- Hypocalcemia

- Thyroid dysfunction

- Wound healing complications

Hypertension is one of the most common adverse effects of lenvatinib therapy and is more prominent in subjects older than 75 years.